HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CalEPA

This article was originally published in The Rose Sheet

Executive Summary

Reviewing several cosmetics ingredients for potential of the chemicals to be carcinogenic under Proposition 65. Allyl isovalerate is listed on the California Environmental Protection Agency's "high" carcinogenicity concern list, released Feb. 19. Use of the ingredient in various cosmetics, foods and household products is not known, and allyl isovalerate is not listed in the Cosmetic, Toiletry and Fragrance Association's International Ingredient Dictionary. C.I. acid red 51 and acid blue 9 and its salts made CalEPA's "not high" carcinogenicity concern list. CalEPA will hold a workshop to review public comments and peer review data on April 9. Written comments are due by April 20

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel